Jasper Therapeutics, Inc.
JSPR
$2.92
-$0.04-1.35%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.51M | 48.80M | 71.64M | 92.50M | 106.82M |
| Total Receivables | -- | -- | -- | 250.00K | 250.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.52M | 1.82M | 1.57M | 1.09M | 1.04M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.94M | 2.56M | 2.60M | 968.00K | 575.00K |
| Total Current Assets | 42.97M | 53.17M | 75.81M | 94.81M | 108.68M |
|
|
|||||
| Total Current Assets | 42.97M | 53.17M | 75.81M | 94.81M | 108.68M |
| Net Property, Plant & Equipment | 2.89M | 3.47M | 2.85M | 3.18M | 3.67M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 609.00K | 949.00K | 1.24M | 1.43M | 1.58M |
| Total Assets | 46.47M | 57.60M | 79.90M | 99.41M | 113.93M |
|
|
|||||
| Total Accounts Payable | 8.03M | 3.00M | 4.03M | 3.09M | 2.96M |
| Total Accrued Expenses | 10.41M | 6.73M | 9.52M | 7.47M | 5.61M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.95M | 1.84M | 1.09M | 1.06M | 1.03M |
| Total Finance Division Other Current Liabilities | 105.00K | 770.00K | 597.00K | 849.00K | 467.00K |
| Total Other Current Liabilities | 105.00K | 770.00K | 597.00K | 849.00K | 467.00K |
| Total Current Liabilities | 20.50M | 12.33M | 15.24M | 12.46M | 10.07M |
|
|
|||||
| Total Current Liabilities | 20.50M | 12.33M | 15.24M | 12.46M | 10.07M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 201.00K | 755.00K | 724.00K | 1.01M | 1.29M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 2.26M | 2.26M | 2.26M | 2.26M | 2.26M |
| Total Liabilities | 22.97M | 15.35M | 18.23M | 15.73M | 13.62M |
|
|
|||||
| Common Stock & APIC | 312.33M | 304.35M | 302.54M | 300.23M | 298.22M |
| Retained Earnings | -288.83M | -262.11M | -240.87M | -216.55M | -197.91M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 23.50M | 42.24M | 61.67M | 83.68M | 100.31M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 23.50M | 42.24M | 61.67M | 83.68M | 100.31M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 23.50M | 42.24M | 61.67M | 83.68M | 100.31M |
|
|
|||||